ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.


Player Avatar pchop123 (80.23) Submitted: 11/25/2012 7:31:16 PM : Underperform Start Price: $2.23 ACAD Score: -129.74

not that impressed at least in the short term

Report this Post 2 Replies
Member Avatar MMCapitalMgmt (99.82) Submitted: 11/27/2012 4:26:06 PM
Recs: 1

Good call on this one LOL

Member Avatar techvisions (< 20) Submitted: 12/12/2012 4:27:13 PM
Recs: 0

MM is kind of unecessarily rude to our Pchop or porkchop friend. Don't know Pchop, but he's often to sometimes right and no "pork".

Featured Broker Partners